5 May 2020
Two purines, caffeine and urate, have been associated with a reduced risk of Parkinson's disease (PD) in multiple study groups and populations. Analysis of data from the Harvard Biomarkers Study shows that lower levels of caffeine consumption and lower blood urate are inversely associated with PD, strengthening the links between caffeine intake and urate levels and PD, reports a study in JPD.
3 April 2020
Amsterdam, NL – While much attention has focused on the potential for severe respiratory complications and unfavorable outcomes from the COVID-19 pandemic among patients with Parkinson's disease (PD), the impact extends beyond these threats.
12 February 2020
Amsterdam, NL – In order to provide the best medical care for newly diagnosed Parkinson's disease (PD) patients, a method of predicting their cognitive and motor progression, beyond using purely clinical parameters, would have major implications for their management.
11 February 2020
Amsterdam, NL – To better understand the relationship between physical activity and Parkinson's disease (PD) investigators in Sweden analyzed medical records of nearly 200,000 long-distance skiers who took part in the Vasaloppet cross-country ski race.
16 January 2020
Amsterdam, NL – The International Parkinson Disease Genomics Consortium (IPDGC) has now been in existence for ten years.
14 January 2020
15 November 2019
In this review, investigators evaluate the current state of knowledge about the potential for using fecal microbiome transplantation to restore the normal microbial balance of the gut in PD patients. It is published in the open access JPD special issue on "The Gut-Brain Axis in Parkinson's Disease".
14 November 2019
This review evaluates evidence for the association between inflammatory bowel disease (IBD) and PD and proposes directions for future research. It is published in the open access JPD special issue on "The Gut-Brain Axis in Parkinson's Disease".
13 November 2019
Aggregates of the protein alpha-synuclein arising in the gut may play a key role in the development of PD. A new hypothesis relating to alpha-synuclein is being testing and results to date are covered in this review, published in the open access JPD special issue on "The Gut-Brain Axis in Parkinson's Disease".
12 November 2019
Amsterdam, NL – In order to optimally treat motor symptoms in patients with Parkinson's disease (PD), it is necessary to have a good understanding of their severity and daily fluctuations.